CME

CME


Shifting Paradigms for Assessment and Management of Lower-Risk Myelodysplastic Syndromes: Genomics, Risk Stratification, and Novel Therapies

August 31, 2022

Host: Rami Komrokji, MD

Guest: Michael R. Savona, MD

Guest: Jamile Shammo, MD, FASCP, FACP

Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms associated with cytopenias, suboptimal production of mature erythrocytes, an